Page 39 - JCTR-11-1

Journal of Clinical and
Translational Research Dexamethasone in critical COVID-19

doi: 10.1016/S0140-6736(20)30252-X 17. Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment
14. Sharifipour E, Shams S, Esmkhani M, et al. Evaluation of in coronavirus-associated severe acute respiratory
bacterial co-infections of the respiratory tract in COVID-19 syndrome. Kidney Int. 2005;67(2):698-705.
patients admitted to ICU. BMC Infect Dis. 2020;20:646. doi: 10.1111/j.1523-1755.2005.67130.x
doi: 10.1186/s12879-020-05374-z 18. Yang X, Tian S, Guo H. Acute kidney injury and renal
15. Chan L, Chaudhary K, Saha A, et al. AKI in Hospitalized replacement therapy in COVID-19 patients: A systematic
Patients with COVID-19. J Am Soc Nephrol. 2021;32(1): review and meta-analysis. Int Immunopharmacol.
151-160. 2021;90:107159.
doi: 10.1681/ASN.2020050615 doi: 10.1016/j.intimp.2020.107159
16. Ng JH, Hirsch JS, Hazzan A, et al. Outcomes among patients 19. RECOVERY Collaborative Group, Horby P, Lim WS, et al.
hospitalized with COVID-19 and acute kidney injury. Am J Dexamethasone in hospitalized patients with Covid-19.
Kidney Dis. 2021;77(2):204-215.e1. N Engl J Med. 2021;384(8):693-704.
doi: 10.1053/j.ajkd.2020.09.002 doi: 10.1056/NEJMoa2021436

Volume 11 Issue 1 (2025) 33 doi: 10.36922/jctr.24.00036